Do You Know What Your Scribe Did Last Spring? The Impact of COVID-19 on Medical Scribe Workflow.


Journal

Applied clinical informatics
ISSN: 1869-0327
Titre abrégé: Appl Clin Inform
Pays: Germany
ID NLM: 101537732

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 15 12 2020
Statut: ppublish

Résumé

To understand the impact of the shift to virtual medicine induced by coronavirus disease 2019 (COVID-19) has had on the workflow of medical scribes. This is a prospective observational survey-based study. This study was conducted at academic medical center in the United States. Seventy-four scribes working in ambulatory practices within an academic medical center. All medical scribes received a survey assessing their workflow since beginning of COVID-19 restrictions. To assess the current workflow of medical scribes since transition to virtual care. Secondary outcomes are to assess the equipment used and location of their new workflow. Fifty-seven scribes completed the survey. Overall 42% of scribes have transitioned to remote scribing with 97% serving as remote scribes for remote visits. This workflow is conducted at home and with personal equipment. Of those not working as scribes, 46% serve in preclinic support, with a wide range of EHR-related activities being reported. The remaining scribes have been either redeployed or furloughed. The rapid transition to virtual care brought about by COVID-19 has resulted in a dramatic shift in scribe workflow with the adoption of a previously unreported workflow of remote scribing for virtual care. Additional work is now needed to ensure these new workflows are safe and effective and that scribes are trained to work in this new paradigm.

Identifiants

pubmed: 33264803
doi: 10.1055/s-0040-1721396
pmc: PMC7725591
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

807-811

Subventions

Organisme : AHRQ HHS
ID : R01 HS025141
Pays : United States
Organisme : R01HS025141
ID : Agency for Healthcare Research and Quality
Pays : International

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Références

J Am Med Inform Assoc. 2020 Oct 29;:
pubmed: 33120424
J Am Med Inform Assoc. 2020 Jun 1;27(6):957-962
pubmed: 32311034
JAMA. 2015 Apr 7;313(13):1315-6
pubmed: 25504341
J Med Pract Manage. 2013 Sep-Oct;29(2):133-6
pubmed: 24228379
J Urol. 2010 Jul;184(1):258-62
pubmed: 20483153
AMIA Annu Symp Proc. 2020 Mar 04;2019:333-342
pubmed: 32308826
Appl Clin Inform. 2017 Sep 26;8(3):981-993
pubmed: 28956888
Ann Fam Med. 2017 Sep;15(5):427-433
pubmed: 28893812
Am J Otolaryngol. 2020 Sep - Oct;41(5):102611
pubmed: 32580066
J Am Board Fam Med. 2015 May-Jun;28(3):371-81
pubmed: 25957370
JMIR Med Inform. 2017 Sep 20;5(3):e30
pubmed: 28931497
Int J Med Inform. 2019 Mar;123:76-83
pubmed: 30654906
Foot Ankle Spec. 2020 Aug 26;:1938640020950544
pubmed: 32844674

Auteurs

Jeffrey A Gold (JA)

Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon, United States.
Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, Oregon, United States.

James Becton (J)

Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, Oregon, United States.

Joan S Ash (JS)

Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, Oregon, United States.

Sky Corby (S)

Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon, United States.

Vishnu Mohan (V)

Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, Oregon, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH